The People of Tulane Cancer Center Research
Haitao Zhang, Ph.D.
Zhang H, Wu Y, Malewicz B, Lu J, Li S, Marshall J, Ip C, Dong Y. Augmented suppression of androgen receptor signaling by a combination of alpha-tocopheryl succinate and methylseleninic acid. Cancer, 107(12): 2942, 2006.
Wu Y, Zhang H, Dong Y, Park YM, Ip C. A new look into the anticancer mechanism of selenium through the lens of endoplasmic reticulum stress. Cancer Res, 65(19): 9073, 2005.
Dong Y, Zhang H, Gao AC, Marshall JR, Ip C. Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers. Molecular Cancer Therapeutics, 4(7): 1047, 2005.
Zhang H, Dong Y, Zhao H, Brooks JD, Hawthorn L, Nowak N, Marshall JR, Gao AC, Ip C. Microarray data mining for potential selenium targets in chemoprevention of prostate cancer. Cancer Genomics and proteomics, 2:97, 2005.
Park EM, Choi KS, Park SY, Kong ES, Zhang H, Ip C, Park YM. A display thiol-proteomics approach to characterize global redox modification of proteins by selenium: implications for the anticancer action of selenium. Cancer Genomics and Proteomics, 2: 25, 2005.
Zhang H, Zhang H, Lee L, Ip MM. The LIP isoform of C/EBPbeta, but not NFkappaB, mediates the transcriptional inhibition of beta-casein by tumor necrosis factor-alpha (TNF). Endocrinology, 145: 2833, 2004.
Dong Y, Lee SO, Zhang H, Marshall JR, Gao AC, Ip C. Prostate specific antigen (PSA) expression is down-regulated by selenium through disruption of androgen receptor signaling. Cancer Res, 64: 19, 2004.
Dong Y, Zhang H, Hawthorn L, Ganther HE, Ip C. Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Res, 63:52, 2003.
1430 Tulane Ave, New Orleans, LA 70112 504-988-5187 email@example.com